>
India Stock Market Loses 5.5 Trillion Rupees Amid Energy Crisis
US Bond Market Crisis Intensifies Amid Rising Yields
Critical Minerals Supply Chain Under Siege Amid Geopolitical Tensions
BEANS, BEEF AND BOEING: PPI INFLATION TAKES FLIGHT
US To Develop Small Modular Nuclear Reactors For Commercial Shipping
New York Mandates Kill Switch and Surveillance Software in Your 3D Printer ...
Cameco Sees As Many As 20 AP1000 Nuclear Reactors On The Horizon
His grandparents had heart disease.
At 11, Laurent Simons decided he wanted to fight aging.
Mayo Clinic's AI Can Detect Pancreatic Cancer up to 3 Years Before Diagnosis–When Treatment...
A multi-terrain robot from China is going viral, not because of raw speed or power...
The World's Biggest Fusion Reactor Just Hit A Milestone
Wow. Researchers just built an AI that can control your body...
Google Chrome silently installs a 4 GB AI model on your device without consent
The $5 Battery That Never Dies - Edison Buried This 100 Years Ago

"Kidney stone disease has been rising in recent years, affecting roughly 10% of people," says Jeremy Burton, from St. Joseph's Health Care London. "While previous research has shown a connection between the gut microbiome and kidney stones in those who have taken antibiotics, we also wanted to explore the connection to other microbiomes in the hopes we can advance understanding and potential treatments."
Using a specific genetic analysis technique, researchers from Lawson Health Research Institute and Western University scientists examined the microbe makeup of the three regions in 83 patients who had kidney stones, as well as those of 30 healthy people. What they found was that those with kidney stones had changes in not one but all three microbiomes. The patients with the formed kidney stones also had at least 90 days since taking antibiotics – which has previously been linked to stone prevalence.